1352834-55-9

Basic information

• Product Name: (4-(5-chlorobenzo[d]oxazol-2-yl)-7-Methyl-1,4-diazepan-1-yl)(5-Methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)Methanone
• Synonyms: (4-(5-chlorobenzo[d]oxazol-2-yl)-7-Methyl-1,4-diazepan-1-yl)(5-Methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)Methanone
• CAS NO: 1352834-55-9
• Molecular Formula: C₂₃H₂₃ClN₆O₂
• Molecular Weight: 450.92072
• Mol File: 1352834-55-9.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 669.8±65.0 °C(Predicted)
• Appearance: /
• Density: 1.41±0.1 g/cm3(Predicted)
• PKA: 1.47±0.40(Predicted)
• CAS DataBase Reference: (4-(5-chlorobenzo[d]oxazol-2-yl)-7-Methyl-1,4-diazepan-1-yl)(5-Methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)Methanone(CAS DataBase Reference)
• NIST Chemistry Reference: (4-(5-chlorobenzo[d]oxazol-2-yl)-7-Methyl-1,4-diazepan-1-yl)(5-Methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)Methanone(1352834-55-9)
• EPA Substance Registry System: (4-(5-chlorobenzo[d]oxazol-2-yl)-7-Methyl-1,4-diazepan-1-yl)(5-Methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)Methanone(1352834-55-9)

Safety Data

• Hazardous Substances Data: 1352834-55-9(Hazardous Substances Data)

Usage

General Description

The chemical "(4-(5-chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone" is a complex compound that contains a benzoxazole moiety, a diazepane ring, a triazole ring, and a ketone functional group. It is a potential pharmaceutical agent with diverse biological activities such as antimicrobial, antifungal, and antitumor properties. The molecule has the potential to be used in drug development and may possess therapeutic potential for various medical conditions. Its unique structure and combination of functional groups make it a promising candidate for further study and exploration in the field of medicinal chemistry.

Upstream product

• 22876-19-3 5-chloro-2-mercaptobenzoxazole 
• 3621-81-6 2,5-dichloro-1,3-benzoxazole 
• 1001401-59-7 (7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone 
• 1104546-96-4 5-methyl-2-(2Η-1,2,3-triazol-2-yl)benzoyl chloride 
• 90673-37-3 7-methyl-1,4-diazepan-5-one 
• 95-85-2 2-hydroxy-5-chloro-aniline 
• 52548-14-8 2-iodoyl-5-methylbenzoic acid 
• 17200-29-2 5-chloro-benzoxazole 
• 1352834-54-8 benzyl 5-methyl-4-(5-methyl-2-(2H-1,2,3-triazole-2-yl)benzoyl)-1,4-diazepane-1-carboxylate 
• 1352834-53-7 (rac)-benzyl 5-methyl-1,4-diazepane-1-carboxylate hydrochloride 
• 1030377-24-2 1-benzyl 4-tert-butyl 5-methyl-1,4-diazepane-1,4-dicarboxylate 
• 1030377-23-1 benzyl (2-((tert-butoxycarbonyl)amino)ethyl)(3-oxobutanoyl)carbamate 
• 956317-36-5 2-(2H-1,2,3-triazol-2-yl)-5-methylbenzoic acid 
• 2941-78-8 2-Amino-5-methylbenzoic acid 

Relevant articles and documents

PROCESS FOR THE RESOLUTION OF (R,S)-DIAZEPANE AND DIAZEPANONE DERIVATIVES

The present invention relates to a process for the preparation of an acid salt (T) of a compound of formula (A) (A) as well as to the acid salt (T) and the compound (A) as such,wherein R1 is selected from the group consisting of H, PG1 and RA, with RA being or and wherein PG1 is a suitable protecting group, and wherein n is 0 or 1, wherein the acid salt (T) is the salt of one stereoisomer of a chiral acid, preferably wherein the chiral acid salt is a tartaric acid derivative salt, preferably wherein the tartaric acid derivative salt is selected from the group consisting of 2,3-ditoluoyl tartaric acid salt, 2,3-dibenzoyl tartaric acid salt, 2,3-dianisoyl tartaric acid salt, 2,3-dibenzoyl tartaric acid mono(dimethylamide) salt and a mixture of two or more thereof. Further the present invention relates to use of (T) and/or (A) for the preparation of suvorexant.